Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
Oslin DW, Lynch KG, Shih MC, Ingram EP, Wray LO, Chapman SR, Kranzler HR, Gelernter J, Pyne JM, Stone A, DuVall SL, Lehmann LS, Thase ME; PRIME Care Research Group; Aslam M, Batki SL, Bjork JM, Blow FC, Brenner LA, Chen P, Desai S, Dieperink EW, Fears SC, Fuller MA, Goodman CS, Graham DP, Haas GL, Hamner MB, Helstrom AW, Hurley RA, Icardi MS, Jurjus GJ, Kilbourne AM, Kreyenbuhl J, Lache DJ, Lieske SP, Lynch JA, Meyer LJ, Montalvo C, Muralidhar S, Ostacher MJ, Paschall GY, Pfeiffer PN, Prieto S, Przygodzki RM, Ranganathan M, Rodriguez-Suarez MM, Roggenkamp H, Schichman SA, Schneeweis JS, Simonetti JA, Steinhauer SR, Suppes T, Umbert MA, Vassy JL, Voora D, Wiechers IR, Wood AE. Oslin DW, et al. Among authors: dieperink ew. JAMA. 2022 Jul 12;328(2):151-161. doi: 10.1001/jama.2022.9805. JAMA. 2022. PMID: 35819423 Free PMC article. Clinical Trial.
Reduced alcohol use in patients prescribed pioglitazone.
Dieperink E, Hauser P, Dockter K, Miranda J, Evenson M, Thuras P. Dieperink E, et al. Am J Addict. 2021 Nov;30(6):570-577. doi: 10.1111/ajad.13214. Epub 2021 Aug 19. Am J Addict. 2021. PMID: 34414623
Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes.
Hagedorn HJ, Wisdom JP, Gerould H, Pinsker E, Brown R, Dawes M, Dieperink E, Myrick DH, Oliva EM, Wagner TH, Harris AHS. Hagedorn HJ, et al. Among authors: dieperink e. Addict Sci Clin Pract. 2019 Jul 10;14(1):24. doi: 10.1186/s13722-019-0151-7. Addict Sci Clin Pract. 2019. PMID: 31291996 Free PMC article.
S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder.
Loftis JM, Valerio J, Taylor J, Huang E, Hudson R, Taylor-Young P, Chang M, Ho SB, Dieperink E, Miranda JL, Hauser P. Loftis JM, et al. Among authors: dieperink e. Alcohol Clin Exp Res. 2018 Jun 28:10.1111/acer.13796. doi: 10.1111/acer.13796. Online ahead of print. Alcohol Clin Exp Res. 2018. PMID: 29953169 Free PMC article.
Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.
Peterson K, Dieperink E, Anderson J, Boundy E, Ferguson L, Helfand M. Peterson K, et al. Among authors: dieperink e. Psychopharmacology (Berl). 2017 Jun;234(11):1649-1661. doi: 10.1007/s00213-017-4622-9. Epub 2017 Apr 29. Psychopharmacology (Berl). 2017. PMID: 28456840 Review.
35 results